Collectively, these findings identify astrocytic WNT5B–NFATc2–MMP14 signaling as a critical pathological mechanism in HD and establish genistein as a promising modulator of astrocytic dysfunction with therapeutic potential. Here, NFATC2 is linked to Huntington disease.